Board of Directors
The Leukemia & Lymphoma Society's (LLS's) Board of Directors for FY15 is comprised of distinguished individuals dedicated to LLS's mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
James H. Davis, Ph.D., JD
Chair of the Board
Dr. Davis is the former Executive Vice President, General Counsel and Secretary of Human Genome Sciences, Inc., a biopharmaceutical company that pioneered new treatments in the areas of auto-immune diseases, cancer and bioterrorism.. His professional background has focused on the intersection of science, business and law, particularly in issues related to the commercialization of new technologies. Dr. Davis continues to consult with biotechnology and other companies in the area of crisis management and the launch of new technologies.
Dr. Davis has been counsel to a major intellectual property firm; a partner in the Washington, D.C. office of a major New York law firm; head of research and development for an agricultural biotechnology company; and a Special Assistant at the Environmental Protection Agency, where he focused on biotechnology regulation. He is a CML patient and a clinical trial participant. Jim began his term on the National Board in 2007 and serves as vice-chair of the Board of Directors, chair of the Mission Oversight Committee and on the Therapy Acceleration Program, Medical & Scientific Affairs and Executive committees. I also have served for two years as the Co-Chair of the National Capital Area annual Leukemia Ball helping the chapter to raise approximately $6 million. Term ends: 2016.
Elizabeth J. (Betsy) Clark, Ph.D.
Betsy Clark is the executive director of the National Association of Social Workers - the largest organization of professional social workers, with nearly 150,000 members. Her clinical specialty is oncology social work. Clark has conducted research, developed service delivery programs and published papers and book chapters on psychosocial oncology, cancer survivorship, and loss and bereavement. She is an editor of the book Social Work and Oncology: Supporting Survivors, Families, and Caregivers, published by the American Cancer Society, and she serves on the editorial boards of CURE: Cancer Updates, Research, and Education, and the journal Illness, Crisis, and Loss. Clark is a member of the Academy of Certified Social Workers, and was recently elected to the National Academies of Practice. She holds bachelor and master degrees in social work, a master of public health from the University of Pittsburgh, and master and doctorate degrees in medical sociology from the University of North Carolina at Chapel Hill. Clark joined the National Board in 2009 and serves on the Board Development, Patient Services, and Public Policy committees. Term ends: 2015.
Ken Schwartz is a transaction advisory services partner with Ernst & Young LLP. He has been providing services to both private equity and corporate acquirers for the past ten years. Schwartz's experience includes complex, cross-border mergers, acquisitions, divestitures and recapitalizations. He has led teams working on transactions ranging from $5 million to more than $25 billion. Schwartz is a certified public accountant with more than 17 years of experience. He earned his bachelor's degree from the State University of New York at Albany. He is a member of the American Institute of Certified Public Accountants and the Long Island chapter of the New York State Society of Certified Public Accountants. Schwartz joined the National Board in 2010 and served on the Audit and Investment committees. Term ends: 2016.
Donald Proctor is a senior vice president at Cisco in the Office of the Chairman and CEO. As the leader of Cisco's Cybersecurity Task Force, he works with Cisco customers, partners, and worldwide government leaders in defense, civilian agencies, and the intelligence community to advance the safety, privacy, and integrity of their critical network infrastructure. A graduate of the University of California, Berkeley, Proctor is also part of the professional faculty in the Management of Technology graduate program at UC Berkeley's Haas School of Business and formerly taught in the UC Berkeley Extension Telecommunications Engineering certification program. Term ends: 2016.
Board of Directors
James A. Beck
Jim Beck is a certified financial planning practitioner and major shareholder and principal of Hefren-Tillotson, a Pittsburgh-based financial planning and investment firm. He has more than 25 years of experience in investments and financial planning. Beck's indirect involvement with LLS dates back to 1951, when his 4-year-old brother lost his battle with leukemia. He has been active in his local chapter in numerous capacities over the past 25 years, including chapter president and treasurer. Beck joined the National Board in 2008, and has served on the Donor Development, Finance, and Investment committees and is a member of the Canadian Board. Term ends: 2017.
William G. Behnke
Bill Behnke is the founder and president of The Behnke Group, founded in 2005. He is a senior executive with extensive background in direct sales, marketing, sales management, and business development, with a specialization in the health care market. He has more than 15 years of experience selling to CEOs, CFOs, CMOs, and boards of directors of health insurance companies and hospitals, and has significant success raising capital from venture capital firms, private equity firms, and accredited private investors. Behnke has been a member of the South Texas chapter since 2005. He has been instrumental in opening doors; most recently he has recruited and supported the last two Men of the Year candidates. Term ends: 2017.
Jorge Benitez joined Accenture in 1981 after graduating cum laude from the University of Florida with degrees in accounting and economics. With more than 28 years of experience in management consulting, technology and outsourcing, Benitez's specialty is directing large-scale global-change initiatives across a diverse set of industry segments. Throughout his career, Benitez has been recognized by his peers and clients for his ability to lead with a keen focus on both people and business results. He has led the minority mentoring program for Accenture's US business, global people advocacy worldwide, and the global partner matters function for Accenture. Benitez's success in business and the community has been recognized on a local and national level. He was selected in 2005 as one of the Top 100 Most Influential Hispanics in the United States. Benitez has been a member of the Southern Florida chapter since 2008, joined the National Board in 2010, and has served on the Board Development and Finance committees and the Strategic Plan Task Force. Term ends: 2016.
James E. Bradner, M.D.
James E. Bradner, M.D., is a staff physician in the Division of Hematologic Malignancies at Dana-Farber Cancer Institute, as well as an assistant professor of medicine at Harvard Medical School. He is a member of the American Society of Clinical Investigation, the American Society of Hematology, the American Chemical Society and the American Association of Cancer Research. Bradner received his AB from Harvard University, his medical degree from the University of Chicago, and his MMS from Harvard Medical School. His awards and honors include the Damon Runyon-Rachleff Innovation Award, the Smith Family Award for Excellence in Biomedical Research, the Dunkin Donuts Rising Star Award, and the HMS Distinguished Excellence in Teaching Award. For the past five years, Bradner has worked closely with The Leukemia & Lymphoma Society. The Bradner laboratory is the grateful recipient of two competitive Specialized Center of Research (SCOR) grants, which have catalyzed the development of a new prototype drug for leukemia and another for Multiple Myeloma and Non-Hodgkin lymphoma. In addition, the Therapeutics Acceleration Program (TAP) continues to support the clinical development of two drugs from the Bradner laboratory now in clinical trials. Dr. Bradner joined the LLS National Board in 2012. Term ends: 2015.
Peter Brock has been developing commercial real estate in the New York and Florida markets since 1975. For the past 10 years, he's been a principal in Brock Development and has developed major retail projects in the Florida area. Brock founded two land and development funds that have invested in commercial real estate in Florida, Texas, Arizona, Colorado, Tennessee, New Mexico and California. He has served on the investment committee of those funds for the past four years. He is the founder of Brock Services Corporation, a hotel management company. Brock has been a member of the Palm Beach Area chapter since 2004, and assists with donor development by personally contacting donors and sharing his story. Brock graduated with a bachelor's degree in economics from the University of Pennsylvania's Wharton School of Finance & Commerce; and holds a master of business administration degree from the Columbia Graduate School of Business. Term ends: 2017.
Dana A. Callow, Jr.
Dana Callow is the managing partner of Boston Millennia Partners, and co-founded Boston Capital Ventures in 1982. He was a senior consultant at Braxton Associates, an international strategic planning firm. He worked with Fortune 100 companies in strategic planning and implementing merger and acquisition strategies. Callow is currently presiding director and chair of the governance committee of PAREXEL International Corporation, a $1-billion-plus clinical-trials management company. He is also a director of jobs for Massachusetts, a Massachusetts-based non-profit organization comprised of business and political leaders, including the governor and congressional leaders. Callow is a member of the advisory board of the Dartmouth/Tuck Center for Private Equity and Entrepreneurship; a member of the Board of Trustees and the chairman of the Investment Committee at Tufts University; and serves on the board of overseers at Tufts University Medical School. He was a major sponsor for the Massachusetts Chapter's gala and Black Tie event. Callow is a magna cum laude graduate of Tufts University, and holds a master's of business administration degree from the Amos Tuck School at Dartmouth College. Term ends: 2017.
Scott A. Carroll
Scott A. Carroll is the resident manager of the Cincinnati, Ohio office of Jackson Lewis LLP. Carroll has represented clients across the spectrum of labor and employment law, including wrongful discharge litigation, collective bargaining, union avoidance, and human resources counseling. He has expertise in drafting, counseling, prosecuting, and defending theft-of-trade-secret cases and/or non-compete, non-solicitation cases. Carroll is a member of the U.S. Sixth Circuit Bar Association, the Federal Bar Association, the Ohio State Bar Association, and the Cincinnati Bar Association. He received his bachelor's of science degree from the University of Cincinnati in 1990, and he earned his JD from The College of Law at the University of Cincinnati in 1993, where he was a member of the University of Cincinnati Law Review. Carroll became a member of the South Ohio chapter in 2002 and was chapter president in 2005. Term ends: 2017.
William S. Dalton, M.D., Ph.D.
William S. Dalton, Ph.D., M.D., is the founder and CEO of M2Gen, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton is the past president, CEO & center director of Moffitt Cancer Center. Prior to that role, Dr. Dalton was dean of the University of Arizona, College of Medicine. He is interested in the development of personalized cancer care and patient-centered outcomes research. Dr. Dalton's basic and translation research interests focus on molecular mechanisms of drug resistance and drug discovery in hematologic malignancies. He has more than 200 publications, serves on several editorial boards, and has numerous patents in the fields of drug discovery and personalized medicine. Term ends: 2017.
Timothy S. Durst
Tim Durst is a partner with Baker Botts LLP, an international law firm. He works in the firm's Dallas office. His law practice focuses on commercial and intellectual property litigation matters, such as patent infringement and trade secret misappropriation cases. Durst's involvement in the Society stems from his son's diagnosis - just short of his second birthday in 1997 - of ALL. His son is now a healthy, thriving, ten-plus-year survivor. Durst has worked on the North Texas Chapter Board since 1999, including serving two terms as president. He has participated in Team In Training, Light The Night, and local golf and black-tie events. Since joining the National Board in 2006, Durst has worked on board development, public policy, and TAP matters, and chaired the 2007 Volunteer Leadership Conference and the Board Development Committee. Term ends: 2015.
Graciela C. Eleta
Marketing executive Graciela C. Eleta's most recent position was as senior vice president for Univision's Brand Solutions Team, a strategy and insights discipline at the leading Spanish-language media company in the United States. Eleta joined Univision in early 2008 to lead this newly-created consulting practice, where she was instrumental in helping enroll more than 100 new brands into the Hispanic market. Before Univision, Eleta worked at Procter & Gamble for 21 years, most recently as vice president for multicultural business development. In that capacity, she was responsible for developing marketing and retail strategies to appeal to Hispanic and African American consumers across the company's largest brands. Eleta previously served as general manager for P&G's Puerto Rico subsidiary, where she successfully launched brands like Pantene, Olay and Swiffer. She earned a bachelor of arts degree in economics, magna cum laude, from Wellesley College and a master's degree in business administration from Boston College. Eleta serves on three other boards and continues her Hispanic consulting work. Term ends: 2016.
Bernard H. Garil
Bernie Garil is a retired investment adviser and broker-dealer executive and former president of OpCap Advisors, a subsidiary of Oppenheimer Capital. He is a director or trustee of 16 investment companies for which UBS Global Asset Management (Americas) Inc. serves as investment advisor, sub-advisor, or manager, and is a member of the Audit and Nominating committees of each of the funds. Garil is a member of the board of directors, Chairman of the Examining Committee, and a member of Trust Investment and Operating committees of OFI Trust Company. Since 1976, Garil has been a volunteer for The Leukemia & Lymphoma Society as a donor, past member of the National Board of Directors (1987-1995), a trustee of the New York City chapter (1976-1995) and president of the chapter (1982-1985). He graduated from Brooklyn College with a bachelor of science degree in accounting and did graduate work in finance at American University. Garil currently serves on the investment committee of LLS and the Brooklyn College Foundation, as well as working on investment issues at UBS and OFI Trust Company. Term ends: 2017.
Beth E. Hawley
Beth E. Hawley became involved with LLS after a friend's young daughter was diagnosed with Non-Hodgkin lymphoblastic lymphoma nine years ago. She currently serves as chief customer experience officer for Cogent HMG, the nation's largest privately-held hospitalist company, where she oversees performance, value, innovation, reporting and marketing. She is co-author of the Greeno-Hawley Hospital Medicine IndexTM, the first objective tool designed to measure the capabilities of a hospitalist program. Hawley holds a bacehlor's of science degree from Drexel University, a master of business administration from Eastern University, a certificate in occupational therapy from the University of Pennsylvania and a green belt in six-sigma certification from Villanova University. She serves on the Society of Hospital Medicine (SHM) Practice Analysis Committee. Hawley is a fellow with the American College of Healthcare Executives (ACHE) and a member of the Medical Group Management Association (MGMA). Term ends: 2015.
Francie Heller, is the managing partner at Heller Advisory. Ms. Heller has more than two decades of financial experience in both the public and private sectors and has served as managing director at Houlihan Lokey, where she ran the pension, endowment and foundation advisory group. Prior to that, Ms. Heller was a managing director at Chilton Investment Company. Before Chilton, she served as senior managing director at Bear Stearns & Co., Inc., and president of MBIA Municipal Investors Service Corporation and was also an education director in the New York City public schools for several years. Ms. Heller earned a bachelor's degree from Boston University, a master's equivalent degree from the University of Georgia, and a professional diploma from Fordham University. She currently serves on the board for Furman University and several other educational not for profit organizations. In addition, Heller is an advisor to the Government Finance Officer Association's committee on retirement and benefits administration. Term ends: 2017.
Raanan Horowitz is the president and chief executive officer of Elbit Systems of America, LLC, a leading provider of high-performance products and systems solutions for the defense, homeland security, commercial aviation, and medical instrumentation markets. Horotwitz leads the strategic and operational direction of the Fort Worth-headquartered company, and serves as a member of the Elbit Systems of America board of directors. During his tenure with the company, he has been instrumental in driving its organic growth and strategic acquisitions, resulting in its evolution to providing mission-critical systems to many major defense platforms. Horowitz is active in the defense and aerospace industry through his service in the U.S. Army Science Board. He serves on the Board of Governors of the Aerospace Industry Association and is a member of the Business Executives for National Security (BENS). He received a master's of business administration from the Seidman School of Business at Grand Valley State University in Allendale, Michigan, and was also awarded a master of science degree in electrical engineering and a bachelor of science degree in mechanical engineering from Tel-Aviv University in Israel. Horowitz joined the National Board in 2008, and serves on the Finance and Board Development committees and the Strategic Plan Task Force. Term ends: 2017.
Richard M. Jeanneret
Rich Jeanneret is the americas vice chair of transaction advisory services (TAS) and is a member of the Americas executive board at Ernst & Young. Jeanneret was formerly the mid-atlantic managing partner of the assurance and advisory business services practice - more than 1,000 professionals providing assurance and business advisory services to its clients in that region. Jeanneret has 26 years of experience providing advisory and consulting services to private equity, financial services, real estate, and hospitality industry clients. He has extensive transactional expertise, and has worked on several mergers and acquisitions with financial buyers and spinoffs from public companies. Jeannert received his bachelor of arts in economics from Boston College and is a member of the American Institute of Certified Public Accounts. He has been active with a number of charitable and civic activities over the course of his career. Jeanneret has been a member of the National Capital Area chapter since 1999 and has chaired or served on the Black Tie Committee for nine years. Term ends: 2017.
Joseph B. Kelley
Joe Kelley is vice president, government affairs for Eli Lilly and Company, where he serves as the head of Lilly's Washington office and is responsible for Lilly's federal, state, and international government affairs activities. He has been an active member of LLS's National Capital chapter, where he served on the Executive Committee, and co-chairs the chapter's highly successful Annual Leukemia Ball. Kelley has been responsible for raising significant funds for this very successful event. He established the Virginia Sheldon Jerome Foundation in memory of his wife, who he lost to AML in 2002. Kelley has also assisted with LLS's government affairs activities to help secure funding for blood cancer research. Kelley joined the National Board in 2009 and serves on the Public Policy and Board Development committees. Term ends: 2015.
Ralph E. Lawson, FHFMA, CPA
Ralph Lawson is the executive vice president and chief financial officer of Baptist Health South Florida, Inc. Baptist Health owns six hospitals and 21 satellite outpatient centers, and is the largest private employer in Miami-Dade County. Baptist operates in three counties with over 14,000 employees, and has been recognized as one of the 100 Best Employers in America for the last eight years by Fortune Magazine. Lawson earned a bachelor of science degree from the University of Colorado and a master degree in business administration from The Wharton School of Finance, University of Pennsylvania. He also serves as chairman of the Board of Catholic Health Services and is the former National Chair of the Healthcare Financial Management Association (HFMA). Term ends: 2016.
Michelle Le Beau, Ph.D.
Michelle Le Beau, Ph.D., director of Cancer Cytogenetics Laboratory, Arthur and Marian Edelstein Professor of hematology/oncology at the University of Chicago, and director of the University of Chicago Comprehensive Cancer Center. In her role as director of the University of Chicago Comprehensive Cancer Center, an NCI-designated Cancer Center, Dr. Le Beau oversees cancer research, education and outreach programs. She has expertise in developing research teams, and advancing multidisciplinary and transdisciplinary research. Dr. Le Beau received her bachelor's degree in animal science/genetics from Purdue University, her master's degree in pathology and her doctorate in pathology and genetics from the University of Illinois. She completed her postdoctoral training at the University of Chicago. Dr. Le Beau currently serves as the President of the Association of American Cancer Institutes, and is a member of the board of directors of the American Association for Cancer Research, and the executive committee of the American Society of Hematology, and serves on the National Cancer Policy Forum of the Institute of Medicine (National Academy of Sciences). Term ends: 2017.
Gilles Legault is senior counsel, global legal affairs at CN. As a lawyer, he is primarily involved in CN's supply chain solutions businesses, including trucking, international freight forwarding, customs brokerage and distribution. Legault also manages CN's insurance programs and is involved in internal financing. For the last 15 years, Legault has acquired board-related experience at local, national and international levels, in public and commercial corporations. He is past chair of the Chartered Institute of Logistics and Transport in North America headquartered in Ottawa (Ontario) and affiliated to CILT (UK). Legault's involvement with LLS stems from the loss of his father-in-law due to secondary AML, which deprived his three young boys of a loving grandfather and his wife of a great dad. Currently the Chairman of the Board of Directors of The Leukemia & Lymphoma Society of Canada (since October 2012), Legault has chaired the Montreal Leadership Committee of the Light The Night (LTN) Walk of the Quebec Chapter of LLSC from 2010 to 2012 and was the Corporate Chair of Montreal's LTN Walk 2010. Term ends: 2016.
Connie L. Lindsey
Connie L. Lindsey is Executive Vice President and Head of Corporate Social Responsibility and Global Diversity & Inclusion at Northern Trust, Chicago. In addition, Ms. Lindsey provides oversight and leadership to the firm's response to environmental matters as well as social issues, within the marketplace, workplace, and the community. Prior to becoming the Head of CSR, Ms. Lindsey led the client servicing teams in the Public Entities and Institutions segment in the Corporate & Institutional Services business, serving public fund and not-for-profit clients. Ms. Lindsey is the immediate Past National Board President of Girl Scouts of the USA, the highest-ranking volunteer of this 3.4 million-member organization. Ms. Lindsey is a founding member of the Advisory Board of the Center for Green Schools, a member of the Economic Club of Chicago, Executive Leadership Council, Executives' Club of Chicago, Friends of Prentice Women's Board member at Northwestern Memorial Hospital, and a member of the Board of Governors of the Metropolitan Club of Chicago. She is a Leadership Greater Chicago Fellow in the class of 2001. Ms. Lindsey attended the University of Wisconsin-Milwaukee, where she majored in finance and has completed the Harvard Business School Executive Education Corporate Social Responsibility program. Term ends: 2017.
Steven T. Rosen, M.D., FACP
Dr. Steven T. Rosen is the Provost, Chief Scientific Officer and Director of the Cancer Center for the City of Hope. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. He served as the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine from 1989-2014. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies. Dr. Rosen has received numerous grant awards and contracts and has published more than 300 scientific papers. Dr. Rosen was the recipient of Northwestern University Medical School's Alumni Achievement Award (1994), the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996), recognition from the Woman's Board of Northwestern Memorial Hospital for Compassionate Care (1996), and Israel Cancer Research Fund, Man of Distinction Award (2011). He is acknowledged in Best Doctors in America and Best Doctors in Chicago. Term ends: 2017.
Franklin O. Smith, III, M.D.
Franklin O. Smith, III, M.D., is Vice President for Medical Affairs at Medpace and adjunct professor of medicine and pediatrics at the University of Cincinnati College Of Medicine. Prior to joining Medpace, Dr. Smith served as the Clinical Director of the University of Cincinnati Cancer Institute at the University of Cincinnati. Previously, Smith served as the Director of the Division of Hematology/Oncology at Cincinnati Children's Hospital Medical Center and as the Vice Chair of the Children's Oncology Group. He received his bachelor of science degree from Wofford College and his medical degree from the University of South Carolina School Of Medicine. Smith was a resident in pediatrics at the University of Florida College of Medicine and did fellowship training in pediatric hematology/oncology at the University of Washington and the Fred Hutchinson Cancer Research Center. He has clinical expertise in hematopoietic stem cell transplantation. Dr. Smith's research focus is acute myeloid leukemia and Fanconi anemia. He has more than 150 scientific publications. He has served on the LLS Board for the Indiana and Tri-State chapters and is currently a member of the LLS Medical and Scientific Affairs and Mission Oversight Committees. Term ends: 2015.
Kathryn C. Vecellio
Kathryn Vecellio is a trustee of her family's foundation and volunteer for many community and charitable organizations for the past 36 years. In addition to holding a board position with the LLS Western Pennsylvania and West Virginia chapter, Vecellio serves on the boards of the Kravis Center for the Performing Arts and Harvard's affiliate, the Schepens Eye Research Institute. She also currently serves on the boards of the Norton Museum of Art, her family's foundation, and The Leadership Board of the Cleveland Clinic Florida and Cleveland Clinic Heart and Vascular Institute Leadership Commission in Cleveland. Vecellio has received many awards, including the Women in Leadership Award from the Executive Women of the Palm Beaches and the Outstanding Volunteer Fundraiser Award from the Association of Fundraising Professionals. Term ends: 2017.
Louise G. Warner
Louise Warner has been involved with LLS since 1999, and has been very active at both the local and national levels. She served as chapter president and secretary and chaired numerous Black Tie events, Light The Night, and the Donor Development Committee. Warner completed the Disney half-marathon with Team In Training in 2003. She served as the first Chair of the Board of Representatives, and has been involved in strategic planning, organizational design and planning volunteer leadership conferences. Warner co-chaired task forces on volunteer engagement and chapter president best practices, and is currently a member of the Board Development Committee. She joined the National Board in 2008. Warner serves on the Board Development and Patient Services committees and chairs the Strategic Plan Task Force. She lost her mother to lymphoma in 2004. Term ends: 2017.
Keith S. White
Keith S. White, chief executive officer of ParkerWhite, developed this San Diego-based company into a premier national branding agency, bringing more than 15 years of brand development, marketing, sales, consumer and business management experience to the agency. Throughout his career, White, a multi-disciplinary marketing professional, has built powerful consumer and trade brands in the marketplace and has successfully launched and grown many well-known consumer brands. He has been the lead brand strategist on Star Trac Fitness, Donjoy, Zimmer Medical, Next Proteins, Airwalk, and Westec Security (ADT). In his spare time, White has launched a data-mining marketing firm, AtomicMinds; a real estate investment firm, Sottaku Doji; and a charity for keeping America's youth active, American Youth Fitness Organization (AYFO). All three organizations are active today. His undergraduate work started at Auburn University in the sciences, and he completed his bachelor degree in communications at the University of California, San Diego. Term ends: 2015.
Meet our Executive Leadership Team
Meet our Medical and Scientific Advisory Board